December 30, 2014
At last, X-factor time: stocks that end in X are special this week.
Or shall we say 2x, as in doubling in the space of hours -- on millions of shares exchanged. Our special situations are getting a choose one: ski-lift; face lift; gift lift.
The very definition of Special Situation, in the financial world, makes it almost a sure thing that these rapid, small-company gainers will continue their parabola into 2015. In many ways, these companies -- Sysorex Global, BioCryst Pharma, Natcore Technology -- are our candidates for Illumina status. Illumina is the genomics data company that made many of us here in California wealthy beyond our wildest dreams.
Please go to:
https://thomcalandra.com/?p=41152
For the actionable bits of this X-file, that is. For TCR subscribers only, please.
See: Why Sysorex, BioCryst & Others Are Enriching TCR
-- Thom Calandra
See: a thomcalandra.com home for our expanding TCR family.
THE CALANDRA REPORT
$129 yearly: Does Not Recur
THE CALANDRA REPORT
$129: Will Recur Yearly
Thom Calandra & TCR are researchers and investors. They are not registered investment advisers, nor do they wish to be. The research and material they offer to subscribers are meant as editorial opinion.